VFC
45
3
MMM
30
2
PVH
63
5
BF.B
53
5
NDAQ
48
3
CF
38
-3
CL
77
2
CAG
39
5
MU
43
-4
BMY
43
8
VZ
25
-2
AVY
74
2
SHW
61
2
HPE
46
-5
SWKS
57
-8
LEG
20
-8
GILD
50
13
DE
29
-3
ICE
67
3
ECL
84
14
VFC
45
3
MMM
30
2
PVH
63
5
BF.B
53
5
NDAQ
48
3
CF
38
-3
CL
77
2
CAG
39
5
MU
43
-4
BMY
43
8
VZ
25
-2
AVY
74
2
SHW
61
2
HPE
46
-5
SWKS
57
-8
LEG
20
-8
GILD
50
13
DE
29
-3
ICE
67
3
ECL
84
14
Financhill
Back

Advantage Solutions Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
22

ADV
Advantage Solutions

Last Price:
2.90
Seasonality Move:
-9.62%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
22
Advantage Solutions (ADV) is a Sell

Is Advantage Solutions a Buy, Sell or Hold?

  • The current Advantage Solutions [ADV] share price is $2.91. The Score for ADV is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADV Stock Price Chart

What is Advantage Solutions's stock price today?

  • The Advantage Solutions share price today is $2.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADV is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 39.12 Sell
Chaikin Money Flow: 949889 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.91 - 3.47) Sell
Bollinger Bands (100): (3.37 - 4.35) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

ADV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.92 Sell
20-day SMA: 3.12 Sell
50-day SMA: 3.7 Sell
200-day SMA: 3.44 Sell
8-day EMA: 2.93 Sell
20-day EMA: 3.11 Sell
50-day EMA: 3.48 Sell
200-day EMA: 3.47 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Advantage Solutions Earnings Growth & ADV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.03 per share, and an increase next year of $0.07 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Advantage Solutions Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):